As health insurance giants Cigna and Anthem seek regulatory approval for a controversial merger, they have been ramping up their spending on lobbying, enlisting an army of former government officials with ties to the key public officials who can influence the antitrust review process. The lobbying push comes as groups representing phyisicans and consumers have argued that the merger — which would create the largest private health insurance company in history — could raise premiums and limit medical care for more than 53 million people.
Featured News
EU Moves to Rein in National Interference in Corporate Mergers
Mar 18, 2026 by
CPI
Germany Targets Fuel Price Spikes With New Daily Cap on Increases
Mar 17, 2026 by
CPI
Visa and Mastercard Win Right to Appeal UK Ruling on Interchange Fees
Mar 17, 2026 by
CPI
Spain’s Antitrust and Energy Watchdog to Release Blackout Report Without Blame
Mar 17, 2026 by
CPI
White House, GOP Again Trying to Enact Federal Preemption of State AI Laws
Mar 17, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Behavioral Economics
Feb 22, 2026 by
CPI
Behavioral Antitrust in 2026
Feb 22, 2026 by
Maurice Stucke
Behavioral Economics in Competition Policy: Going Beyond Inertia and Framing Effects
Feb 22, 2026 by
Annemieke Tuinstra & Richard May
Agreeing to Disagree in Antitrust
Feb 22, 2026 by
Jorge Padilla
Recognizing What’s Around the Corner: Merger Control, Capabilities, and the New Nature of Potential Competition
Feb 22, 2026 by
Magdalena Kuyterink & David J. Teece